Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | Leptin | 1 | ng/mL | 1 | IL-16 | 24.0 | 31 | ||||
| N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 1 | IL-16 | 19.5 | 62 | |
| N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | IL-16 | 19.0 | 55 | |
| N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | IL-16 | 21.0 | 31 | |
| N2586 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | IL-16 | 19.5 | 46 | |
| N2586 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 1 | IL-16 | 18.0 | 30 | |
| RA2159 | 1 | IL-16 | 0 | ||||||||
| RA2159 | PD184352 | 0.1 | uM | 1 | IL-16 | 0 | |||||
| RA2159 | Lestaurtinib | 0.3 | uM | 1 | IL-16 | 0 | |||||
| RA2159 | Ruxolitinib | 0.3 | uM | 1 | IL-16 | 0 | |||||
| RA2159 | Tofacitinib | 0.3 | uM | 1 | IL-16 | 0 | |||||
| RA2159 | IKK16 | 2.0 | uM | 1 | IL-16 | 0 | |||||
| RA2159 | 1 | IL-16 | 0 | ||||||||
| N2586 | 1 | IL-16 | 0 | ||||||||
| N2586 | PD184352 | 0.1 | uM | 1 | IL-16 | 0 | |||||
| N2586 | Lestaurtinib | 0.3 | uM | 1 | IL-16 | 0 | |||||
| N2586 | Ruxolitinib | 0.3 | uM | 1 | IL-16 | 0 | |||||
| N2586 | Tofacitinib | 0.3 | uM | 1 | IL-16 | 0 | |||||
| N2586 | IKK16 | 2.0 | uM | 1 | IL-16 | 0 | |||||
| N2586 | 1 | IL-16 | 0 | ||||||||
| RA2159 | Visfatin | 1 | ng/mL | 1 | IL-16 | 21.0 | 57 | ||||
| RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | IL-16 | 17.5 | 60 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-16 | 18.0 | 50 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-16 | 15.0 | 70 | |
| RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-16 | 18.0 | 70 |